Three-year data have confirmed the effectiveness of a strategy that eliminated all third-generation cephalosporins from a formulary as a means to control the emergence of vancomycin-resistant enterococcus (VRE).

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Elimination of third-generation cephalosporins improves VRE infection rate control

Newsletter